Wearable Breast Pump (Model S36)
Shenzhen TPH Technology Co., Ltd. · Decision date Sep 17, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 17, 2026 for the Wearable Breast Pump (Model S36), submitted by Shenzhen TPH Technology Co., Ltd. of Shenzhen, China, under 510(k) number K254203. The device falls under regulation 884.5160, classification name Pump, Breast, Powered, product code HGX, in the Obstetrics/Gynecology specialty and review panel. The record lists the application as a Traditional 510(k), received December 29, 2025, not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan.
SESE means FDA cleared the submission as substantially equivalent to a predicate device; it is not a PMA approval. The available summary excerpt describes the S36 as a powered breast pump intended for lactating women to express and collect milk, and states that performance testing demonstrated it is as safe and effective as the predicate. The predicate device, the specific testing performed, and any labeling or indication details are not included in the public information, so those points remain unverified here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Obstetrics/Gynecology
- Decision date
- Sep 17, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K254203
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Shenzhen TPH Technology Co., Ltd.
- Product code
- HGX
- Decision code
- SESE
- Decision date
- Sep 17, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Pump, Breast, Powered.
- Applicant
- Shenzhen TPH Technology Co., Ltd.
- Product code
- HGX
- FDA device class
- 2
FDA decision timeline
K254203 received
Application receipt date recorded by FDA.
K254203 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HGX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Nenesupply Co., Ltd. | 510(k) clearance | Oct 29, 2026 | FDA | |
| Tomy International, Inc. | 510(k) clearance | Oct 16, 2026 | FDA | |
| Philips Consumer Lifestyle B.V. | 510(k) clearance | Sep 3, 2026 | FDA | |
| Guangdong Horigen Mother & Baby Products Co., Ltd. | 510(k) clearance | Sep 1, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shenzhen TPH Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K254203
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

